10x Genomics (TXG) Operating Margin (2018 - 2026)

10x Genomics has disclosed Operating Margin across 9 years of filings, most recently posting 12.95% for Q2 2026.

• In Q2 2026, Operating Margin fell 3037.0% year-over-year to 12.95%; the TTM figure through Jun 2026 stood at 14.33% (up 127.0% YoY), while the FY2025 annual figure was 9.49%, up 2237.0% from the prior year.
• Operating Margin came in at 12.95% for Q2 2026 at 10x Genomics, down from 11.3% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 17.42% in Q2 2025 to a low of 61.7% in Q3 2023.
• Average Operating Margin over 5 years is 28.02%, with a median of 28.68% recorded in 2023.
• Year-over-year, Operating Margin tumbled 4616 bps in 2022 and jumped 4468 bps in 2025.
• Over 5 years, Operating Margin stood at 14.78% in 2022, then plunged by 103 bps to 30.0% in 2023, then slipped by 1 bps to 30.2% in 2024, then soared by 61 bps to 11.77% in 2025, then fell by 10 bps to 12.95% in 2026.
• Per Business Quant data, the three most recent Operating Margin figures were 12.95% in Q2 2026, 11.3% in Q1 2026, and 11.77% in Q4 2025.